2vty: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Seed}}
[[Image:2vty.png|left|200px]]


<!--
==Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain swapped dimer==
The line below this paragraph, containing "STRUCTURE_2vty", creates the "Structure Box" on the page.
<StructureSection load='2vty' size='340' side='right'caption='[[2vty]], [[Resolution|resolution]] 2.10&Aring;' scene=''>
You may change the PDB parameter (which sets the PDB file loaded into the applet)
== Structural highlights ==
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
<table><tr><td colspan='2'>[[2vty]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Vaccinia_virus Vaccinia virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VTY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2VTY FirstGlance]. <br>
or leave the SCENE parameter empty for the default display.
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1&#8491;</td></tr>
-->
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2vty FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2vty OCA], [https://pdbe.org/2vty PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2vty RCSB], [https://www.ebi.ac.uk/pdbsum/2vty PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2vty ProSAT]</span></td></tr>
{{STRUCTURE_2vty|  PDB=2vty  |  SCENE=  }}
</table>
== Function ==
[https://www.uniprot.org/uniprot/F1_VACCA F1_VACCA] Protein with a BCL2-like fold which is essential for survival of infected cells.
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Apoptosis is an important part of the host's defense mechanism for eliminating invading pathogens. Some viruses express proteins homologous in sequence and function to mammalian pro-survival Bcl-2 proteins. Anti-apoptotic F1L expressed by vaccinia virus is essential for survival of infected cells, but it bears no discernable sequence homology to proteins other than its immediate orthologues in related pox viruses. Here we report that the crystal structure of F1L reveals a Bcl-2-like fold with an unusual N-terminal extension. The protein forms a novel domain-swapped dimer in which the alpha1 helix is the exchanged domain. Binding studies reveal an atypical BH3-binding profile, with sub-micromolar affinity only for the BH3 peptide of pro-apoptotic Bim and low micromolar affinity for the BH3 peptides of Bak and Bax. This binding interaction is sensitive to F1L mutations within the predicted canonical BH3-binding groove, suggesting parallels between how vaccinia virus F1L and myxoma virus M11L bind BH3 domains. Structural comparison of F1L with other Bcl-2 family members reveals a novel sequence signature that redefines the BH4 domain as a structural motif present in both pro- and anti-apoptotic Bcl-2 members, including viral Bcl-2-like proteins.


===VACCINIA VIRUS ANTI-APOPTOTIC F1L IS A NOVEL BCL-2-LIKE DOMAIN SWAPPED DIMER===
Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.,Kvansakul M, Yang H, Fairlie WD, Czabotar PE, Fischer SF, Perugini MA, Huang DC, Colman PM Cell Death Differ. 2008 Oct;15(10):1564-71. Epub 2008 Jun 13. PMID:18551131<ref>PMID:18551131</ref>


 
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
<!--
</div>
The line below this paragraph, {{ABSTRACT_PUBMED_18551131}}, adds the Publication Abstract to the page
<div class="pdbe-citations 2vty" style="background-color:#fffaf0;"></div>
(as it appears on PubMed at http://www.pubmed.gov), where 18551131 is the PubMed ID number.
== References ==
-->
<references/>
{{ABSTRACT_PUBMED_18551131}}
__TOC__
 
</StructureSection>
==About this Structure==
[[Category: Large Structures]]
2VTY is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Vaccinia_virus Vaccinia virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VTY OCA].
 
==Reference==
Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands., Kvansakul M, Yang H, Fairlie WD, Czabotar PE, Fischer SF, Perugini MA, Huang DC, Colman PM, Cell Death Differ. 2008 Oct;15(10):1564-71. Epub 2008 Jun 13. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18551131 18551131]
[[Category: Single protein]]
[[Category: Vaccinia virus]]
[[Category: Vaccinia virus]]
[[Category: Pdbx_ordinal=, <PDBx:audit_author.]]
[[Category: Colman PM]]
[[Category: Apoptosis]]
[[Category: Czabotar PE]]
[[Category: Bcl-2]]
[[Category: Fairlie WD]]
[[Category: Vaccinia virus]]
[[Category: Fischer SF]]
 
[[Category: Huang DCS]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 24 20:11:52 2008''
[[Category: Kvansakul M]]
[[Category: Perugini MA]]
[[Category: Yang H]]

Latest revision as of 14:17, 3 January 2024

Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain swapped dimerVaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain swapped dimer

Structural highlights

2vty is a 1 chain structure with sequence from Vaccinia virus. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:X-ray diffraction, Resolution 2.1Å
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

F1_VACCA Protein with a BCL2-like fold which is essential for survival of infected cells.

Publication Abstract from PubMed

Apoptosis is an important part of the host's defense mechanism for eliminating invading pathogens. Some viruses express proteins homologous in sequence and function to mammalian pro-survival Bcl-2 proteins. Anti-apoptotic F1L expressed by vaccinia virus is essential for survival of infected cells, but it bears no discernable sequence homology to proteins other than its immediate orthologues in related pox viruses. Here we report that the crystal structure of F1L reveals a Bcl-2-like fold with an unusual N-terminal extension. The protein forms a novel domain-swapped dimer in which the alpha1 helix is the exchanged domain. Binding studies reveal an atypical BH3-binding profile, with sub-micromolar affinity only for the BH3 peptide of pro-apoptotic Bim and low micromolar affinity for the BH3 peptides of Bak and Bax. This binding interaction is sensitive to F1L mutations within the predicted canonical BH3-binding groove, suggesting parallels between how vaccinia virus F1L and myxoma virus M11L bind BH3 domains. Structural comparison of F1L with other Bcl-2 family members reveals a novel sequence signature that redefines the BH4 domain as a structural motif present in both pro- and anti-apoptotic Bcl-2 members, including viral Bcl-2-like proteins.

Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.,Kvansakul M, Yang H, Fairlie WD, Czabotar PE, Fischer SF, Perugini MA, Huang DC, Colman PM Cell Death Differ. 2008 Oct;15(10):1564-71. Epub 2008 Jun 13. PMID:18551131[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

  1. Kvansakul M, Yang H, Fairlie WD, Czabotar PE, Fischer SF, Perugini MA, Huang DC, Colman PM. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ. 2008 Oct;15(10):1564-71. Epub 2008 Jun 13. PMID:18551131 doi:cdd200883

2vty, resolution 2.10Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA